Veeva CRM is the life-sciences industry CRM from Veeva Systems, headquartered in Pleasanton, California, and one of the largest vertical-SaaS success stories of the past two decades. The product is specifically positioned for pharmaceutical, biotechnology and medical-device sales representatives who call on healthcare professionals (HCPs) such as doctors, hospital procurement and pharmacists, with the regulatory compliance and detailed sample-management requirements that this regulated industry demands. Veeva CRM is built on a dedicated multi-tenant SaaS platform (Veeva Vault and the Veeva Commercial Cloud) and is the dominant CRM for pharma sales globally, with the major life-sciences groups using it across DACH and worldwide deployments.
Product overview
Veeva CRM is a vertical CRM product designed specifically for pharma and life-sciences sales execution. Functional scope includes HCP master data with healthcare-specific attributes (specialty, prescribing patterns, account affiliation), call planning and execution, sample distribution and reconciliation with full regulatory traceability, presentation and content management for compliant detail-aid delivery, multi-channel engagement covering face-to-face, remote-detail, email and approved-email workflows, and integration with Veeva's broader life-sciences platform for content management and clinical data. The product is delivered as multi-tenant SaaS with regular release cycles. Implementation is delivered through Veeva's direct services or specialised life-sciences partners.
Functional sweet spot
The functional sweet spot is pharmaceutical, biotechnology and medical-device organisations of any size whose primary go-to-market is sales-rep-driven HCP engagement under regulatory oversight. Veeva CRM is purpose-built for this vertical and is not a generic CRM replacement. The key differentiated capabilities — sample-management with chain-of-custody for regulated samples, approved-email with content-approval workflows tied to medical-legal-regulatory review, integration with Veeva Vault for content and CTMS, and the deep HCP data model with industry-standard healthcare reference data — are difficult to replicate on a horizontal CRM like Salesforce or Microsoft Dynamics 365 even with extensive customisation. Conversely, for non-pharma B2B sales, Veeva CRM is the wrong tool: a horizontal CRM with broader integration ecosystem will fit better.
DACH positioning
Veeva operates established DACH presence through its life-sciences customer base — the major German, Austrian and Swiss pharma groups use the product alongside global pharma deployments. The DACH localisation covers German-language user interface, the relevant regional regulatory requirements (the German pharmacy law, AMG, and the Swiss therapeutic-products legislation), German-language reference data for HCPs and healthcare institutions, and the GDPR-aware data handling that pharma compliance teams require. Data residency is in EU data centres for European customers, which is a regulatory requirement for handling HCP personal data in this industry. The product does not address DATEV or general SMB DACH localisation — it is not a German Mid-Market CRM but a global industry CRM with DACH deployment depth.
Pricing and implementation
Veeva CRM pricing is enterprise SaaS — high per-user-per-month list price (typically several hundred euro per rep per month depending on modules and tier), with separate licensing for Veeva Vault and other Commercial Cloud components. For a typical 500-rep pharma deployment, all-in TCO over five years lands in the 10 to 25 million euro range, with implementation services representing a smaller share than for traditional on-premises pharma CRM because the product is largely standardised on the Veeva data model. Implementation cycles run 6 to 18 months for the full Commercial Cloud rollout. The pricing model is not designed for smaller organisations — for biotech start-ups under 30 reps, generic CRM products with light pharma extensions are typically the more economic starting point.
Selection considerations
Veeva CRM is the natural choice for pharmaceutical, biotechnology and medical-device organisations with sales-rep-driven HCP engagement under regulatory oversight, particularly when sample management, approved-email and integration with Veeva Vault are operational requirements. It is the wrong tool for non-pharma B2B sales (Salesforce or Dynamics 365 Sales fit better), for very small biotech start-ups under 30 reps where the licensing economics are unfavourable, or for organisations already heavily committed to Salesforce as the corporate CRM platform without a separate pharma-specific deployment. Note: Veeva announced strategic migration away from the Salesforce platform onto its own Vault Commercial Cloud platform, completed for many customers — buyers should plan with this technology direction in mind.
Editorial assessment of Veeva CRM — CRM Software Vendors
Spezialisiertes CRM für die Pharma-Industrie auf Salesforce-Plattform — Market Leaders für Außendienst-Steuerung in Life Sciences.
Strong at
pharma compliance: FDA 21 CFR Part 11, EU-MDR-konforme Außendienst-Workflows out-of-the-box — ist die De-facto-Standardlösung für Pharma-Vertrieb.
Salesforce-Plattform-Pros: Profitiert von Salesforce-Cloud-Reife, Marketplace und kontinuierlichen Innovationen.
Veeva Vault-Integration: Native integration an Veeva Vault (Dokumentenmanagement, Regulatory) — Komplett-Stack für regulierte Branche.
Watch out for
Industries-Limitierung: Klar Pharma/Life Sciences fokussiert — für andere Industries nicht relevant; auch innerhalb Pharma teilweise teurer als allgemeine CRMs.
Lizenzkosten-Niveau: Premium-Pricing — passt zu Pharma-Industries-Budgets, ist aber für Mid-Market-Pharma-Akteure relevant zu prüfen.
Editorial assessment by erp-software.org based on publicly available sources,
Hersteller-Dokumentation und DACH-Markt-Beobachtung. Last updated: Mai 2026.
Write Sie uns Ihre experience with Veeva CRM. We publish reviews after a brief editorial check in 1–3 business days. Fields marked with * are required.
Frequently Asked Questions
Is Veeva CRM still on the Salesforce platform?
Veeva is migrating away from the Salesforce platform onto its own Vault Commercial Cloud. Many customers have completed or are in transition. New deployments are positioned on the Vault platform. Buyers should plan capacity, integration and skills around the Vault platform as the strategic direction.
Can Veeva CRM be used outside life sciences?
No. Veeva CRM is purpose-built for pharmaceutical, biotech and medical-device sales execution. For non-pharma B2B sales, horizontal CRMs like Salesforce or Microsoft Dynamics 365 Sales are the correct choice.
Is Veeva CRM available in EU data centres?
Yes. EU data residency is supported and is a regulatory requirement for handling HCP personal data under GDPR in this industry. DACH customers run on EU infrastructure.
What does Veeva CRM cost?
Enterprise SaaS pricing — typically several hundred euro per rep per month depending on modules and tier, plus separate licensing for related Veeva Commercial Cloud components. For a 500-rep deployment, all-in TCO over five years is in the 10 to 25 million euro range.